Status: current, Defined. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2535350018 | Selective adhesion molecule inhibitor | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3520821011 | Substance with selective adhesion molecule inhibitor mechanism of action (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3559317015 | Substance with selective adhesion molecule inhibitor mechanism of action | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Selective adhesion molecule inhibitor | Is a | Immunosuppressant | false | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Has disposition | Selective adhesion molecule inhibitor | true | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Has disposition | Immunomodulator | false | Inferred relationship | Some | ||
| Selective adhesion molecule inhibitor | Is a | Receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Crizanlizumab | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | |
| Alpha-4 integrin receptor antagonist | Is a | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | |
| Selective adhesion molecule inhibitor-containing product | Has active ingredient | True | Selective adhesion molecule inhibitor | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR